These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 30756120)

  • 1. Implementing a Memory Clinic Model to Facilitate Recruitment into Early Phase Clinical Trials for Mild Cognitive Impairment and Alzheimer's Disease.
    Park L; Kouhanim C; Lee S; Mendoza Z; Patrick K; Gertsik L; Aguilar C; Gullaba D; Semenova S; Jhee S
    J Prev Alzheimers Dis; 2019; 6(2):135-138. PubMed ID: 30756120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.
    Kirsebom BE; Espenes R; Waterloo K; Hessen E; Johnsen SH; Bråthen G; Aarsland D; Fladby T
    J Alzheimers Dis; 2017; 60(4):1621-1631. PubMed ID: 28984581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.
    Walter S; Langford OG; Clanton TB; Jimenez-Maggiora GA; Raman R; Rafii MS; Shaffer EJ; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):234-241. PubMed ID: 32920625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of physician referral for patient recruitment to Alzheimer disease clinical trials.
    Galvin JE; Meuser TM; Boise L; Connell CM
    Alzheimer Dis Assoc Disord; 2009; 23(4):352-6. PubMed ID: 19561438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward clinical trials across the Alzheimer's disease spectrum.
    Nuño MM; Gillen DL; Dosanjh KK; Brook J; Elashoff D; Ringman JM; Grill JD
    Alzheimers Res Ther; 2017 Oct; 9(1):81. PubMed ID: 28978335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstacles and opportunities in Alzheimer's clinical trial recruitment.
    Watson JL; Ryan L; Silverberg N; Cahan V; Bernard MA
    Health Aff (Millwood); 2014 Apr; 33(4):574-9. PubMed ID: 24711317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological, Psychiatric, and Functional Correlates of Clinical Trial Enrollment.
    Hammers DB; Foster NL; Hoffman JM; Greene TH; Duff K
    J Prev Alzheimers Dis; 2019; 6(4):242-247. PubMed ID: 31686096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.
    Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C
    J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alzheimer's Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer's-Focused Studies.
    Langbaum JB; High N; Nichols J; Kettenhoven C; Reiman EM; Tariot PN
    J Prev Alzheimers Dis; 2020; 7(4):242-250. PubMed ID: 32920626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A collaborative Alzheimer disease research exchange using a community-based Helpline as a recruitment tool.
    Austrom MG; Bachman J; Altmeyer L; Gao S; Farlow M
    Alzheimer Dis Assoc Disord; 2010; 24 Suppl():S49-53. PubMed ID: 22720321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the Open Screening Programs in Recruiting Subjects to Prodromal and Mild Alzheimer's Disease Clinical Trials.
    Wójcik D; Szczechowiak K; Zboch M; Pikala M
    J Prev Alzheimers Dis; 2020; 7(4):251-255. PubMed ID: 32920627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.
    Ho J; Pond GR; Newman C; Maclean M; Chen EX; Oza AM; Siu LL
    BMC Cancer; 2006 Nov; 6():263. PubMed ID: 17092349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study partners: essential collaborators in discovering treatments for Alzheimer's disease.
    Largent EA; Karlawish J; Grill JD
    Alzheimers Res Ther; 2018 Sep; 10(1):101. PubMed ID: 30261910
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.